The Pap smear, the most common screening tool for cervical cancer, is almost 100 years old. It’s also expensive, painful, time-consuming from sample to diagnosis, and employs antiquated technology.
With regular screening and follow-up care, cervical cancer is the most preventable form of cancer affecting women today. However, current forms of testing and diagnosis are outdated and ineffective.
The study is completed during the time of the consultation.
Obtaining results in minutes, during the consultation.
Accuracy in tissue reading above 90%, surpassing the low percentage (40%) offered by the current Pap Smear test.
Affordable prices to allow all women, everywhere, the access to modern screening tests that can save their lives.
Combining advanced spectroscopy methods with data insights and
Artificial Intelligence algorithms